PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s ImmunityBio IBRX Stock Holding History

PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12	Closed	-$24	–	546
2025 Q4	$24	Hold	12	–	–	﹤0.01%	531
2025 Q3	$30	Hold	12	–	–	﹤0.01%	536
2025 Q2	$32	Hold	12	–	–	﹤0.01%	493
2025 Q1	$36	Hold	12	–	–	﹤0.01%	474
2024 Q4	$31	Hold	12	–	–	﹤0.01%	471
2024 Q3	$45	Hold	12	–	–	﹤0.01%	372
2024 Q2	$76	Hold	12	–	–	﹤0.01%	354
2024 Q1	$64	Hold	12	–	–	﹤0.01%	344
2023 Q4	$60	Hold	12	–	–	﹤0.01%	314
2023 Q3	$20	Sell	12 -5,229	-100%	-$10.5K	﹤0.01%	265
2023 Q2	$33	Buy	5,241 +5,229	+43,575%	+$14.8K	﹤0.01%	266
2023 Q1	$22	Hold	12	–	–	﹤0.01%	318
2022 Q4	$61	Buy	+12	New	+$66	﹤0.01%	260

Other funds holding IBRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s IBRX Position: Q1 2026 in Review

PENSION & WEALTH MANAGEMENT ADVISORS, INC. sold out of ImmunityBio (IBRX) in Q1 2026, closing a stake of 12 shares — an estimated $24 sold.

PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in IBRX in Q4 2022 and held it in 13 quarters. The position peaked at $76 in Q2 2024. 386 funds tracked by Wall St. Rank hold IBRX as of Q1 2026.

PENSION & WEALTH MANAGEMENT ADVISORS, INC. reported no remaining ImmunityBio position as of Q1 2026 after selling out during the quarter.
PENSION & WEALTH MANAGEMENT ADVISORS, INC. sold 12 ImmunityBio shares in Q1 2026, an estimated $24.
PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in ImmunityBio in Q4 2022 and held it in 13 quarters.
PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s ImmunityBio position peaked at $76 in Q2 2024.
386 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2026.

Based on PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s 13F filing for Q1 2026, filed 7 Aug 2026.